Work in Progress

Understanding sources of inefficiency in health care

• A Hard Look at ‘Soft’ Cost‐control Measures in Healthcare Organizations: Evidence from Preferred Drug Policies in Germany. with Daniel Avdic, CINCH working paper series 2021(08). doi: 10.17185/duepublico/74978.
  An earlier version was nomiated as 10% best submissions to Health Care Management Division of the Academy of Management 2021.

• Blankart KE, Lichtenberg FR. The Effects of Off-label Drug Use on Disability and Medical Expenditure. National Bureau of Economic Research; 2022.

Innovators & innovation policy in health care

The Local Influence of Knowledge Production, Pioneers, and Star Researchers on Technology Adoption - Evidence from Cardiovascular Medical Technology, with Meilin Möllenkamp and Jonas Schreyögg. (under review)

Regulation and market design of pharmaceutical and biotechnological markets

Explaining why increases in generic use outpace decreases in brand name medicine use in multisource markets and the role of regulation. with Sotiris Vandoros. (conditional accept, PLOS one)

Deceased papers

• Stakeholder Participation in Regulatory Decision-Making, with Victoria Lauenroth and Tom Stargardt.